Global policies on pharmacy-mediated substitution of biosimilars: a summary

Author(s): Thijs J Giezen, PharmD, PhD, MSc

Abstract: An extensive overview of policies related to pharmacy-mediated substitution of biosimilars across the world was carried out by Larkin et al. in 2017. The details of this are discussed in this commentary. Submitted: 17 November 2017; Revised: 28 November 2017; Accepted: 4 December 2017; Published online first: 15 December 2017 Introduction An extensive overview […]

Read more →